Remiges Ventures, a US-based cross-border venture capital firm with offices in Seattle, WA and Tokyo, Japan, announced today the final closing of its second fund, Remiges BioPharma Fund II raising a total of $95 million, and the launch of RDiscovery, a new life sciences incubator to nurture and advance early-stage therapeutic concepts and technologies.
Read MoreThis week, Keiretsu Forum Mid-Atlantic introduces the next workshop in the Investor Academy series. The group will explore the truths and debunk the myths associated with Life Science Exits.
Read MoreAccording to a report released this week by PitchBook-NVCA Venture Monitor, the first quarter of 2019 shows signs that this year is shaping up to be another very active year for investing, and Keiretsu Forum is leading early-stage funding.
Read MoreKeiretsu Forum Mid-Atlantic will take four portfolio companies to the 2019 Angel Capital Association Summit. Local angels hope that one of the four companies snag "Best of Show," securing a "four-peat" for this angel investment group.
Read MoreWomen 2.0 announces the 9 finalists of the 2010 Women 2.0 Startup Competition, a global competition for early-stage startups in web, mobile and cleantech. Applying companies must have at least one female on the founding team.
Read More